|
1. Choopani A, Golmohmmadi R, Rafati H, Imani Fooladi AA. Prevalence of Staphylococcus aureus strains isolated from wound infection and drug sensitivity pattern, Tehran-Iran (2006-07). J Gorgan Univ Med Sci 2012; 14(3): 135-40. [in Persian] 2. Nubel U, Roumagnac P, Feldkamp M, Song JH, Ko KS, Huang YC, et al. Frequent emergence and limited geographic dispersal of methicillin-resistant Staphylococcus aureus. Proc Nati Acad Sci U S A 2008; 105(37): 14130-5. 3. Sina H, Ahoyo TA, Moussaoui W, Keller D, Bankolé HS, Barogui Y, et al. Variability of antibiotic susceptibility and toxin production of Staphylococcus 2aureus strains isolated from skin, soft tissue, and bone related infections. BMC Microbiol 2013; 13(1): 188. 4. Boan P, Tan HL, Pearson J, Coombs G, Heath CH, Robinson JO. Epidemiological, clinical, outcome and antibiotic susceptibility differences between PVL positive and PVL negativeStaphylococcus aureus infections in Western Australia: a case control study. BMC Infect Dis 2015; 15: 10. 5. Holmes A, Ganner M, McGuane S, Pitt TL, Cookson BD, Kearns AM. Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol 2005; 43(5): 2384-90. 6. Körber A, Schmid E, Buer J, Klode J, Schadendorf D, Dissemond J. Bacterial colonization of chronic leg ulcers: current results compared with data 5 years ago in a specialized dermatology department. J Eur Acad Dermatol Venereol 2010; 24(9): 1017-25. 7. Baba-Moussa L, Anani L, Scheftel JM, Couturier M, Riegel P, Haikou N, et al. Virulence factors producedby strains of Staphylococcus aureus isolated from urinary tract infections. J Hospital Infection 2008; 68(1): 32-8. 8. Baba-Moussa L, Ahissou H, Azokpota P, Assogba B, Atindéhou M, Anagonou S, et al. Toxins and adhesion factors associated with Staphylococcus aureus strains isolated from diarrhoeal patients in Benin. African J Biotechnol 2010; 9(5) . 9. Bohach GA, Fast DJ, Nelson RD, Schlievert PM. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 1990; 17(4): 251-72. 10. Dumitrescu O, Boisset S, Badiou C, Bes M, Benito Y, Reverdy ME, et al. Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin. Antimicrobial Agents Chemotherapy 2007; 51(4): 1515-9. 11. Demling RH, Waterhouse B. The increasing problem of wound bacterial burden and infection in acute and chronic soft-tissue wounds caused by methicillin-resistant Staphylococcus aureus. J Burns Wounds 2007; 7(8). 12. Martins A, Cunha M. Methicillin Resistance in Staphylococcus aureus and Coagulase‐Negative Staphylococci: Epidemiological and Molecular Aspects. Microbiol Immunol 2007; 51(9): 787-95. 13. Bohach GA, Fast DJ, Nelson RD, Schlievert PM. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 1990; 17(4): 251-72. 14. Zhang K, McClure JA, Elsayed S, Louie T, Conly JM. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005; 43(10): 5026-33. 15. Holmes NE, Johnson PD, Howden BP. Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infections. J Clin Microbiol 2012; 50(8): 2548-52. 16. Denton M, O’Connell B, Bernard P, Jarlier V, Williams Z, Henriksen AS. The EPISA study: antimicrobial susceptibility of Staphylococcus aureus causing primary or secondary skin and soft tissue infections in the community in France, the UK and Ireland. J Antimicrobial Chemotherapy 2008; 61(3): 586-8. 17. Cheesbrough M. District laboratory practice in tropical countries: Cambridge university press; 2006. 18. CLSI, Performance Standards for Antimicrobial Susceptibility Testing. 24nd Informational Supplement M100-S24, CLSI, Wayne, Pa, USA; 2014. 19. Murakami K, Minamide W, Wada K, Nakamura E, Teraoka H, Watanabe S. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol 1991; 29(10): 2240-4. 20. Hertl M, Eming R. Autoimmune skin disorders, pemphigus. Autoimmune Diseases of the Skin (Pathogenesis, Diagnosis, Management). 2011; 33-63. 21. Atkinson TP. Immune deficiency and autoimmunity. Curr Opin Rheumatol 2012; 24(5): 515-21. 22. Belgnaoui FZ, Senouci K, Chraibi H, Aoussar A, Mansouri F, Benzekri L, et al. Predisposition to infection in patients with pemphigus. Retrospective study of 141 cases. Presse Med 2007; 36(11 Pt 1): 1563-9. 23. Esmaili N, Mortazavi H, Noormohammadpour P, Boreiri M, Soori T, Vasheghani Farahani I, et al. Pemphigus vulgaris and infections: a retrospective study on 155 patients. Autoimmune Dis 2013; 2013. 24. Chmurova N, Svecova D. Pemphigus vulgaris: a 11-year review. Bratisl Lek Listy 2009; 110(8): 500-3. 25. Kanwar AJ, Dhar S. Factors responsible for death in patients with pemphigus. J Dermatol 1994; 21(9): 655-9. 26. Havaei SA, Ahmadpour M, Poursina F, Ruzbahani M, Assadbeigi B. The prevalence of panton-valentine leukocidin gene in staphylococcus aureus isolated from alzahra hospital Isfahan. Iran J Isfahan Med Sch 2015; 32(31): 219-9. [in Persian] 27. Shariati L, Validi M, Tabatabaiefar MA, Karimi A, Nafisi MR. Comparison of real-time PCR with disk diffusion, agar screen and E-test methods for detection of methicillin-resistant Staphylococcus aureus. Curr Microbiol 2010; 61(6): 520-4. 28. Motamedi H, Rahmat Abadi SS, Moosavian SM, Torabi M. The Association of Panton-Valentine leukocidin and mecA Genes in Methicillin-Resistant Staphylococcus aureus Isolates From Patients Referred to Educational Hospitals in Ahvaz, Iran. Jundishapur J Microbiol 2015; 8(8): e22021. 29. Darabi N, Habibollahi H, Shahbabian K. Molecular epidemiology of Staphylococcus aureus Isolated from patients and personnel in Army hospital. J Army Univ Med Sci I R Iran 2010; 8(3): 193-9. [in Persian] 30. Denton M, O’Connell B, Bernard P, Jarlier V, Williams Z, Henriksen AS. The EPISA study: antimicrobial susceptibility of Staphylococcus aureus causing primary or secondary skin and soft tissue infections in the community in France, the UK and Ireland. J Antimicrobial Chemotherapy 2008; 61(3): 586-8. 31. Elazhari M, Saile R, Dersi N, Timinouni M, Elmalki A, Zriouil SB, et al. Activité de 16 Antibiotiques vis-à-vis des Staphylococcus aureus communautaires à Casablanca (Maroc) et Prévalence des Souches Résistantes à la Méthicilline. Eur J Sci Res 2009; 30: 128-37. 32. Cohen ML. Epidemiology of drug resistance: implications for a post—antimicrobial era. Science 1992; 257(5073): 1050-5. 33. Sina H, Ahoyo TA, Moussaoui W, Keller D, Bankolé HS, Barogui Y, et al. Variability of antibiotic susceptibility and toxin production of Staphylococcus aureus strains isolated from skin, soft tissue, and bone related infections. BMC Microbiol 2013; 13(1): 188. 34. Shariati L, Validi M, Tabatabaiefar MA, Karimi A, Nafisi MR. Comparison of real-time PCR with disk diffusion, agar screen and E-test methods for detection of methicillin-resistant Staphylococcus aureus. Curr Microbiol 2010; 61(6): 520-4. 35. Schneider-Lindner V, Delaney J, Dial S, Dascal A, Suissa S. Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom. Emerg Infect Dis 2007; 13(7): 99.
|
.png)
.png){kind=logo}
